Gainor, J. F., Chi, A. S., Logan, J., Hu, R., Oh, K. S., Brastianos, P. K., . . . Shaw, A. T. (2015). Alectinib Dose Escalation Re-induces Central Nervous System Responses in ALK-Positive Non-Small Cell Lung Cancer (NSCLC) Patients Relapsing on Standard Dose Alectinib. J Thorac Oncol.
Citação norma ChicagoGainor, Justin F., Andrew S. Chi, Jennifer Logan, Ranliang Hu, Kevin S. Oh, Priscilla K. Brastianos, Helen A. Shih, and Alice T. Shaw. "Alectinib Dose Escalation Re-induces Central Nervous System Responses in ALK-Positive Non-Small Cell Lung Cancer (NSCLC) Patients Relapsing On Standard Dose Alectinib." J Thorac Oncol 2015.
Citação norma MLAGainor, Justin F., et al. "Alectinib Dose Escalation Re-induces Central Nervous System Responses in ALK-Positive Non-Small Cell Lung Cancer (NSCLC) Patients Relapsing On Standard Dose Alectinib." J Thorac Oncol 2015.